• Info
  • Significant Ownership

Significant Ownership of Lind Global Fund III LP

Signature - Title
By: Lind Global Partners III LLC, its General Partner, By: /s/ Jeff Easton - Jeff Easton, Managing Member
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Lind Global Fund III LP.

Notify me when Lind Global Fund III LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Lind Global Fund III LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BNGO Bionano Genomics, Inc. Common Stock, $0.0001 par value per share 9.9% $879K -$840K 514K -48.9% Lind Global Fund III LP 30 Sep 2025
SLXN Silexion Therapeutics Corp Ordinary shares, par value $0.0135 per share 6.4% $187K -$10.2K 213K -5.16% Lind Global Fund III LP 30 Sep 2025

Schedules 13D/G Reported by Lind Global Fund III LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.